Behind the Changing Landscape of Chordoma Research and Treatment with Joan Levy, PhD
Originally published on the Cancer Research Institute blog. By Arthur N. Brodsky, PhD Sarcomas are an aggressive type of … Continue reading
Category Archives: Research
Sites for Epizyme’s tazemetostat trials continue to reopen to enrollment
In the ten months since the U.S. Food and Drug Administration (FDA) lifted the partial clinical hold it placed on … Continue reading
Cancer Research Institute and Chordoma Foundation partner to advance immunotherapy research in rare cancer
The Cancer Research Institute (CRI) and Chordoma Foundation announced today that they have established a research partnership to advance treatment … Continue reading
Positive result from ongoing BN-Brachyury clinical trial prompts expansion
We are excited to share a promising milestone in the Foundation-supported Phase 2 BN-Brachyury trial. Yesterday, we received confirmation from … Continue reading
Reflections on the first Pediatric and Young Adult Chordoma Clinic
Last month, on April 16-18, the first-ever chordoma-specific clinic for pediatric and young adult patients was held at the National … Continue reading
Afatinib trial now open at second site
Launched last summer, a Phase 2 clinical trial testing the effectiveness of the targeted therapy afatinib is continuing to enroll … Continue reading
New paper confirms that brachyury is the Achilles’ heel of chordoma, and reveals a new way to attack it
I’m excited to share the findings of a new paper published earlier this week in the journal Nature Medicine that … Continue reading
Grants awarded to two Canadian researchers address key research priorities in chordoma
At the end of 2018, the Chordoma Foundation and the Canadian Cancer Society (CCS) together awarded two new grants totaling … Continue reading
Announcing three new investments to catalyze brachyury drug discovery
We are pleased to announce that the Chordoma Foundation and The Mark Foundation for Cancer Research (MFCR) have together awarded … Continue reading
New chordoma-specific vaccine trial open at Massachusetts General Hospital
Clinicians at Massachusetts General Hospital are now enrolling patients in a new Phase 2 clinical trial sponsored by biotechnology company … Continue reading